Bio-Techne TECH Income Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $311.42M+5.3% | $295.88M+3.3% | $286.56M-9.6% | $316.96M+0.2% | $316.18M+6.4% | ||
| $103.13M-1.4% | $104.6M+6.3% | $98.44M-16.7% | $118.15M+16.3% | $101.63M-1.5% | ||
| $208.29M+8.9% | $191.28M+1.7% | $188.11M-5.4% | $198.81M-7.3% | $214.56M+10.7% | ||
| 66.9%+2.2pp | 64.6%-1.0pp | 65.6%+2.9pp | 62.7%-5.1pp | 67.9%+2.6pp | ||
| $23.46M+1.4% | $23.13M-4.6% | $24.24M-6.9% | $26.03M+5.9% | $24.58M-1.7% | ||
| $109.34M-3.8% | $113.69M-2.2% | $116.21M-40.9% | $196.64M+30.0% | $151.27M+24.6% | ||
| $132.79M-2.9% | $136.82M-2.6% | $140.45M-36.9% | $222.67M+26.6% | $175.85M+20.1% | ||
| $132.79M-2.9% | $136.82M-2.6% | $140.45M-36.9% | $222.67M+26.6% | $175.85M+20.1% | ||
| $75.5M+38.6% | $54.46M+14.3% | $47.66M— | —— | $38.71M-18.4% | ||
| 24.2%+5.8pp | 18.4%+1.8pp | 16.6%— | —— | 12.2%-3.7pp | ||
| —— | —— | —— | $2.13M0.0% | $2.13M0.0% | ||
| —— | —— | —— | $971.5K0.0% | $971.5K0.0% | ||
| -$4.27M-16.1% | -$3.68M-1,204% | $333K— | —— | -$434K+90.4% | ||
| $71.23M+40.3% | $50.78M+5.8% | $47.99M— | —— | $38.27M-10.7% | ||
| $20.18M+57.9% | $12.78M+30.3% | $9.81M— | —— | $15.69M+96.4% | ||
| $51.05M+34.3% | $38.01M-0.5% | $38.19M— | —— | $22.59M-35.3% | ||
| 16.4%+3.5pp | 12.8%-0.5pp | 13.3%— | —— | 7.1%-4.6pp | ||
| $0.32+33.3% | $0.240.0% | $0.24— | —— | $0.14-36.4% | ||
| $0.33+37.5% | $0.24-4.0% | $0.25— | —— | $0.14-36.4% | ||
| 157.4M+0.3% | 157M+0.4% | 156.4M-2.1% | 159.7M+0.5% | 158.9M-1.0% | ||
| 156.3M+0.3% | 155.8M+0.2% | 155.5M-1.3% | 157.5M+0.1% | 157.4M-0.7% | ||
| —— | —— | —— | $971.5K0.0% | $971.5K0.0% | ||
| $46.54M+16.2% | $40.06M+19.0% | $33.67M+649% | $4.49M-82.8% | $26.19M+181% | ||
| -$160K+77.5% | -$711K+57.3% | -$1.67M-113% | -$781K+54.4% | -$1.71M-3,707% | ||
| -$4.51M-320% | $2.05M+145% | -$4.52M-120% | $22.17M+516% | $3.6M+114% | ||
| —— | —— | —— | $207.75K0.0% | $207.75K0.0% | ||
| $23.46M+1.4% | $23.13M-4.6% | $24.24M-6.9% | $26.03M+5.9% | $24.58M-1.7% | ||
| $311.42M+5.3% | $295.88M+3.3% | $286.56M-9.6% | $316.96M+0.2% | $316.18M+6.4% | ||
| $75.5M+38.6% | $54.46M+14.3% | $47.66M— | —— | $38.71M-18.4% | ||
| $99.66M+25.9% | $79.17M+10.0% | $72M— | —— | $66.28M-11.0% | ||
| $99.66M+25.9% | $79.17M+10.0% | $72M— | —— | $66.28M-11.0% | ||
| 32%+5.2pp | 26.8%+1.6pp | 25.1%— | —— | 21%-4.1pp | ||
| $75.5M+38.6% | $54.46M+14.3% | $47.66M— | —— | $38.71M-18.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Bio-Techne's revenue?
- Bio-Techne (TECH) generated $1.2B in revenue over the trailing twelve months, up 0.2% year over year.
- Is Bio-Techne profitable?
- Bio-Techne reported $149.8M in net income over the trailing twelve months, a 10.9% net margin.
- What are Bio-Techne's profit margins?
- Gross margin is 65.0% and operating margin is 14.2%, with a 10.9% net margin.
- What is Bio-Techne's earnings per share?
- Bio-Techne's diluted EPS over the trailing twelve months is $0.94.
- Where does Bio-Techne's income statement data come from?
- Every line is extracted from Bio-Techne's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
